Author:
Ferguson Peter J.,Brisson Alayne R.,Koropatnick James,Vincent Mark D.
Reference23 articles.
1. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and l-histidinol;Warrington;Anticancer Res.,1986
2. Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents;Brandes;J. Clin. Oncol.,1994
3. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists;Brandes;J. Natl. Cancer Inst.,1991
4. Phase III study of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin alone in metastatic/recurrent breast cancer, National Cancer Institute of Canada Clinical Trials Group Study MA.19;Reyno;J. Clin. Oncol.,2004
5. Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases;Raghavan;J. Urol.,2005
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献